Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2010
11/17/2010EP1781627B1 A method for preparing irbesartan and intermediates thereof
11/17/2010EP1585522B1 Quinazolinones as potassium channel modulators
11/17/2010CN101889016A Pyrrolopyrrole derivatives, their manufacture and use
11/17/2010CN101889012A Fungicidal bicyclic pyrazoles
11/17/2010CN101889011A Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3- carboxylic acid amides
11/17/2010CN101889010A Isoxazolo-pyridine derivatives
11/17/2010CN101889004A Inhibitors of protein kinases
11/17/2010CN101885728A Inhibitor of dipeptidyl peptidase IV and application thereof in preventing and treating diabetes
11/17/2010CN101885722A Heterocycle alkyne and benzene compound, medicinal composition and application thereof
11/17/2010CN101885699A Method for synthesizing chiral polycyclic compounds having butyrolactam skeletons
11/16/2010US7834180 contacting a picolinic acid derivative with a benzothiazole derivative or tautomers thereof, in the presence of a non-nucleophilic base; compounds inhibit cell proliferation, induce cell apoptosis and stabilize a quadruplex structure
11/16/2010US7834179 6',7',8',9'-tetrahydro spiro[3H-indole-3,7'-(2H-pyrido[2,1-c][1,2,4]triazine)]-2,3'(1H)-dione compounds; small molecule inhibitors of the MDM2-p53 interaction
11/16/2010US7834175 reacting macrocyclic metal-free cyanine compound dissolved in solvent and vanadium acetylacetonate; low cost
11/16/2010US7834029 For therapy of cancer; treating prostate cancer with 2-(6-methyl-pyridin-2-yl)-3-[6-amido-quinolin-4-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole; TGF-beta signal transduction inhibitors
11/16/2010US7834022 enzyme inhibitor for treating immune-related diseases, skin disorders, myeloid proliferative disorders, cancer; allograft rejection or graft versus host disease
11/16/2010US7834019 3-(2-allyl-6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-3-oxo-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-1-yl)-N,N-dimethylbenzamide; Weel kinase inhibitor; treatment of various cancers; composition with other anticancer agents
11/16/2010US7834014 Parkinson's disease; [2-(7-amino-2-furan-2-yl-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)-octahydro-pyrido[1,2-a]pyrazin-7-yl]-methanol;
11/16/2010US7834012 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
11/16/2010US7834006 antidiabetics; lower blood glucose levels; compounds based on 1H,2H,3H,4H,5H,6H,7H,8H-pyrrolo[3,4-e][1,4]diazepin-6-one
11/16/2010US7834005 anticancer, antiviral, antibiotic use; new derivatives of anthramycin class of antitumor antibiotics
11/16/2010US7833756 Methods of labelling polynucleotides with dibenzorhodamine dyes
11/11/2010WO2010129864A2 Methods and compositions for studying, imaging, and treating pain
11/11/2010WO2010129656A2 Method of oligonucleotide labeling using cycloaddition reaction
11/11/2010WO2010129500A2 Nematocidal sulfonamides
11/11/2010WO2010129379A1 Inhibitors of the renal outer medullary potassium channel
11/11/2010WO2010128995A1 Phenoxymethyl heterocyclic compounds
11/11/2010WO2010128685A1 Alpha helix mimetics and methods relating thereto
11/11/2010WO2010128120A1 Novel indicator platform
11/11/2010WO2010105179A3 Inhibitors of beta-secretase
11/11/2010WO2010080712A3 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
11/11/2010WO2009073497A3 Prolyl hydroxylase inhibitors
11/11/2010US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
11/11/2010US20100286151 1-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of Eating Disorders
11/11/2010US20100286128 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine-receptor ligands
11/11/2010US20100286123 Inhibitors of the renal outer medullary potassium channel
11/11/2010US20100286113 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
11/11/2010US20100286094 Novel compounds of reverse turn mimetics and the use thereof
11/11/2010US20100286088 3-Substituted-4-Oxo-3,4-Dihydro-Imidazo[5,1-d][1,2,3,5-Tetrazine-8-Carboxylic Acid Amides and Their Use
11/11/2010US20100285570 Fluoride processing method
11/11/2010US20100285145 Gpr 119 modulators
11/11/2010US20100284913 Methods and compositions for studying, imaging, and treating pain
11/11/2010CA2761032A1 Phenoxymethyl heterocyclic compounds
11/11/2010CA2760946A1 Methods and compositions for studying, imaging, and treating pain
11/11/2010CA2759399A1 Inhibitors of the renal outer medullary potassium channel
11/11/2010CA2757075A1 Nematocidal sulfonamides
11/10/2010EP2248817A2 Substituted 2-amino-3-sulfonyl-pyrazolo[1,5-a] pyrimidines/antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
11/10/2010EP2248816A2 2-ALKYLAMINO-3-ARYLSULFONYL-CYCLOALCANO [e OR ] PYRAZOLO [1,5-A] PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF
11/10/2010EP2248815A2 3-sulfonyl-pyrazolo[1,5-a]pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
11/10/2010EP2248814A2 SUBSTITUTED CYCLOALCANO[e AND d] PYRAZOLO [1,5-a] PYRIMIDINES/ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS AND METHODS FOR PRODUCTION AND THE USE THEREOF
11/10/2010EP2248802A1 Method for producing isoindole and isoindole produced by the method for producing isoindole
11/10/2010EP2247596A2 Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
11/10/2010EP2247595A1 Pyrrolopyrazine kinase inhibitors
11/10/2010EP2247594A1 Pyrrolopyrimidinecarboxamides
11/10/2010EP2247593A1 Pyrrolopyrazine kinase inhibitors
11/10/2010EP2247592A1 Pyrrolopyrazine kinase inhibitors
11/10/2010EP2247591A1 Pyrrolo [2, 3-d]pyridines and use thereof as tyrosine kinase inhibitors
11/10/2010EP2247590A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine
11/10/2010EP2247185A2 Tyrosine kinase inhibitors
11/10/2010EP2111403B1 Triazabenzo[e]azulene derivatives for the treatment of tumors
11/10/2010EP1742944B1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
11/10/2010CN1635882B Use of composition in preparing medicine for treating hearing loss
11/10/2010CN101883768A Oxazolidinone derivative having 7-membered hetero ring
11/10/2010CN101880347A Process for producing contact product
11/10/2010CN101880283A Azaindole kinase inhibitors
11/10/2010CN101880280A Bicyclic pyrimidinones and uses thereof
11/10/2010CN101880276A Substituted diazepan compounds as orexin receptor antagonists
11/10/2010CN101115754B 5-alkoxyalkyl-6-alkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said substances
11/09/2010US7830702 Synthetic molecular spring device
11/09/2010US7829707 Pyrrolo [3,2-d]pyrimidin-4-one derivatives and their use in therapy
11/09/2010US7829698 Aggregation of particle sizes; active materials; drug loaded into nanoparticles
11/09/2010US7829571 monocyte chemotactic protein antagonists such as -(3S)-1-(4-(tert-butylamino)cyclohexyl)-3-(6-(trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-2-one, used for the treatment of asthma, multiple sclerosis, arteriosclerosis and rheumatoid arthritis
11/09/2010US7829570 Substituted 4-amino isoxazolo[5,4-d]pyrimidines as kinase inhibitors
11/09/2010US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis
11/09/2010CA2530140C Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
11/04/2010WO2010126745A1 SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS β-SECRETASE INHIBITORS
11/04/2010WO2010126552A1 Potent cell-binding agent drug conjugates
11/04/2010WO2010126030A1 Spiroimidazolone derivative
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010125469A1 Pyrimidinedione-fused heterocyclic compounds as trpa1 modulators
11/04/2010WO2010125102A1 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
11/04/2010WO2010125101A1 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine derivatives as p2x7 modulators
11/04/2010WO2010125004A1 Cdk inhibitor salts
11/04/2010WO2010124826A1 Substituted imidazoquinoxalines
11/04/2010WO2010124648A1 Azaazulene compounds
11/04/2010WO2010092111A3 Compounds for non-invasive measurement of aggregates of amyloid peptides
11/04/2010US20100280245 Process and intermediates for the preparation of n-acylated-4-aryl beta-amino acid derivatives
11/04/2010US20100280240 Bicyclic pyrazole compounds as antibacterial agents
11/04/2010US20100280237 Preparation of metal mesoporphyrin compounds
11/04/2010US20100280236 Method for preparing tetrapyrrole compounds and tetrapyrrole compounds
11/04/2010US20100280082 Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as Potentiators
11/04/2010US20100280053 CyclopropylmethYl-[7-(5,7-dimethyl-benzo[1,2,5]thiodiazol-4-yl)-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-4-propyl-amine as a CRF Antagonist
11/04/2010US20100280049 Antagonists of pgd2 receptors
11/04/2010US20100280026 Compositions useful as inhibitors of protein kinases
11/04/2010US20100280015 Noval 1,4-diaza-biclo[3.2.2]nonyl oxadiazolyl derivatives useful as nicotinic acetylcholine receptor ligands
11/04/2010US20100280012 Azaazulene compounds
11/04/2010US20100280004 Small molecule correctors of deltaf508 cftr trafficking
11/04/2010US20100278811 Vasculostatic agents and methods of use thereof
11/04/2010CA2760077A1 Substituted imidazoquinoxalines
11/04/2010CA2760071A1 New process and new compounds
11/04/2010CA2758958A1 Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as .beta.-secretase inhibitors
1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 573